PEAK6 Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$2.44M Buy
105,600
+47,600
+82% +$1.13M 0.01% 1215
2018
Q1
$1.43M Sell
58,000
-142,000
-71% -$3.73M 0.01% 1648
2017
Q4
$5.37M Sell
200,000
-16,000
-7% -$407K 0.03% 783
2017
Q3
$5.2M Buy
216,000
+93,400
+76% +$2.11M 0.03% 721
2017
Q2
$2.63M Buy
122,600
+69,800
+132% +$1.41M 0.02% 1127
2017
Q1
$905K Buy
52,800
+51,800
+5,180% +$902K 0.01% 1770
2016
Q4
$18K Sell
1,000
-48,400
-98% -$877K ﹤0.01% 4451
2016
Q3
$1.03M Buy
49,400
+16,600
+51% +$412K 0.01% 1754
2016
Q2
$882K Buy
+32,800
New +$900K 0.01% 1907
2016
Q1
Sell
-12,800
Closed -$372K 4846
2015
Q4
$372K Buy
+12,800
New +$354K ﹤0.01% 2894
2015
Q3
Sell
-800
Closed -$22K 5447
2015
Q2
$22K Sell
800
-7,800
-91% -$219K ﹤0.01% 4775
2015
Q1
$230K Buy
8,600
+7,600
+760% +$175K ﹤0.01% 3329
2014
Q4
$21K Buy
+1,000
New +$22.3K ﹤0.01% 4363
2014
Q2
Sell
-40,200
Closed -$918K 4973
2014
Q1
$918K Buy
+40,200
New +$856K 0.01% 1954
2013
Q4
Sell
-320,000
Closed -$2.71M 5271
2013
Q3
$2.71M Sell
320,000
-19,000
-6% -$320K 0.02% 1280
2013
Q2
$5.25K Buy
+339,000
New +$5.64M 0.02% 732

Other funds holding NVO

PEAK6 Group's NVO Position: Q2 2018 in Review

PEAK6 Group sold out of Novo Nordisk (NVO) in Q2 2018, closing a stake of 19,544 shares — an estimated $464K sold.

PEAK6 Group first reported a position in NVO in Q2 2013 and held it in 7 quarters. The position peaked at $2.22M in Q1 2016. 537 funds tracked by Wall St. Rank hold NVO as of Q2 2018.

  • PEAK6 Group reported no remaining Novo Nordisk position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 19,544 Novo Nordisk shares in Q2 2018, an estimated $464K.
  • PEAK6 Group first reported a position in Novo Nordisk in Q2 2013 and held it in 7 quarters.
  • PEAK6 Group's Novo Nordisk position peaked at $2.22M in Q1 2016.
  • 537 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.